Indivior Pharmaceuticals
INDV
INDV
95 hedge funds and large institutions have $3.4B invested in Indivior Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
25% more funds holding
Funds holding: 76 → 95 (+19)
2.61% more ownership
Funds ownership: 46.94% → 49.55% (+2.6%)
8% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 26
Holders
95
Holding in Top 10
4
Calls
$64K
Puts
$2K
Top Buyers
| 1 | +$63M | |
| 2 | +$32.8M | |
| 3 | +$21.1M | |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$14.4M |
| 5 |
JP Morgan Chase
New York
|
+$13.9M |
Top Sellers
| 1 | -$42M | |
| 2 | -$31.8M | |
| 3 | -$19.1M | |
| 4 |
JFG
Jefferies Financial Group
New York
|
-$16M |
| 5 |
TSC
Two Seas Capital
Rye,
New York
|
-$10.5M |